Physician profile
John Tokish
NPI 1134119167
$387,316.72
in general payments reported to CMS, 2019-2025
26 companies · $24K in 2025
The $24K reported for 2025 was more than what 91% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92K · 2020: $40K · 2021: $81K · 2022: $14K · 2023: $77K · 2024: $60K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $91K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $39K · Travel and Lodging: $16K · Royalty Or License: $7,519 · Food and Beverage: $6,931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $91,246.35 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $39,420.00 |
| Travel and Lodging | $15,870.96 |
| Royalty Or License | $7,518.68 |
| Food and Beverage | $6,931.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $304,150.52 | 2019-2025 | Arthrex, Arthroplasty Implants Shoulder Arthroplasty & Fracture Univers |
| Depuy Synthes Products, INC. | $56,022.27 | 2019-2022 | |
| Goode Surgical INC | $7,606.34 | 2019-2020 | |
| Medical Device Business Services, INC. | $7,186.65 | 2019-2023 | Biocryl, Dynacord, Bristow Latarjet |
| Impactortho, INC. | $5,378.81 | 2020-2025 | |
| Stryker Corporation | $2,185.46 | 2019-2025 | Aequalis Perform Reversed, Blueprint Patient Specific Instrumentation, Mako |
| Paladin Technology Solutions | $1,363.30 | 2022 | |
| Supreme Orthopedic Systems, LLC | $1,295.06 | 2021 | |
| Smith+Nephew, INC. | $595.35 | 2019-2025 | Aetos Shoulder System, Twinfix, Q-Fix |
| Pacira Therapeutics, INC. | $187.97 | 2019 | |
| Zimmer Biomet Holdings, INC. | $161.77 | 2019-2023 | Tricera Handpiece |
| Music City Medical Technologies, LLC | $151.72 | 2025 | |
| Peerless Surgical INC. | $147.56 | 2025 | |
| Vericel Corporation | $123.72 | 2022 | |
| Steelhead Surgical INC | $121.87 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossur Americas, INC. | $118.72 | 2025 | Unloader One X |
| Miach Orthopaedics, INC. | $113.47 | 2024 | |
| Elite Orthopedics, LLC | $112.59 | 2022 | |
| Medacta USA, INC. | $86.10 | 2022 | |
| Gemini Mountain Medical, LLC | $76.08 | 2021 | |
| Djo, LLC | $46.19 | 2019 | |
| Gemini Medical LLC | $37.13 | 2020 | |
| Lifenet Health | $24.15 | 2025 | Graftlink |
| Orthofix Medical, INC. | $12.47 | 2021 | |
| Depuy Synthes Sales INC. | $11.45 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Tokish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.